These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31035025)

  • 21. Saliva: a fluid of study for OMICS.
    Cuevas-Córdoba B; Santiago-García J
    OMICS; 2014 Feb; 18(2):87-97. PubMed ID: 24404837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear magnetic resonance spectroscopic analysis of salivary metabolome in sarcoidosis.
    Duchemann B; Triba MN; Guez D; Rzeznik M; Savarin P; Nunes H; Valeyre D; Bernaudin JF; Le Moyec L
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Mar; 33(1):10-6. PubMed ID: 27055831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolome analysis for investigating host-gut microbiota interactions.
    Chen MX; Wang SY; Kuo CH; Tsai IL
    J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S10-S22. PubMed ID: 30269936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral Health and the Oral Microbiome in Pancreatic Cancer: An Overview of Epidemiological Studies.
    Bracci PM
    Cancer J; 2017; 23(6):310-314. PubMed ID: 29189325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Not all biofluids are created equal: chewing over salivary diagnostics and the epigenome.
    Wren ME; Shirtcliff EA; Drury SS
    Clin Ther; 2015 Mar; 37(3):529-39. PubMed ID: 25778408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Pilot Characterization of the Human Chronobiome.
    Skarke C; Lahens NF; Rhoades SD; Campbell A; Bittinger K; Bailey A; Hoffmann C; Olson RS; Chen L; Yang G; Price TS; Moore JH; Bushman FD; Greene CS; Grant GR; Weljie AM; FitzGerald GA
    Sci Rep; 2017 Dec; 7(1):17141. PubMed ID: 29215023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NMR analysis of the human saliva metabolome distinguishes dementia patients from matched controls.
    Figueira J; Jonsson P; Nordin Adolfsson A; Adolfsson R; Nyberg L; Öhman A
    Mol Biosyst; 2016 Jul; 12(8):2562-71. PubMed ID: 27265744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between the colonic transcriptome, metabolome, and microbiome in mouse models of obesity-induced intestinal cancer.
    Pfalzer AC; Kamanu FK; Parnell LD; Tai AK; Liu Z; Mason JB; Crott JW
    Physiol Genomics; 2016 Aug; 48(8):545-53. PubMed ID: 27317588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment.
    Zhang A; Sun H; Wang X
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1718-27. PubMed ID: 22971835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
    He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
    Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Saliva and Oral Diseases.
    Martina E; Campanati A; Diotallevi F; Offidani A
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32046271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of the salivary transcriptome as a novel biomarker in determining disease susceptibility.
    Hidayat MFH; Milne T; Cullinan MP; Seymour GJ
    J Periodontal Res; 2018 Jun; 53(3):369-377. PubMed ID: 29280135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Researchers report link between salivary biomarkers, early-stage pancreatic cancer.
    J Am Dent Assoc; 2010 May; 141(5):504. PubMed ID: 20436096
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of a discriminative metabolomic fingerprint of potential clinical relevance in saliva of patients with periodontitis using 1H nuclear magnetic resonance (NMR) spectroscopy.
    Rzeznik M; Triba MN; Levy P; Jungo S; Botosoa E; Duchemann B; Le Moyec L; Bernaudin JF; Savarin P; Guez D
    PLoS One; 2017; 12(8):e0182767. PubMed ID: 28837579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival.
    von Rundstedt FC; Rajapakshe K; Ma J; Arnold JM; Gohlke J; Putluri V; Krishnapuram R; Piyarathna DB; Lotan Y; Gödde D; Roth S; Störkel S; Levitt JM; Michailidis G; Sreekumar A; Lerner SP; Coarfa C; Putluri N
    J Urol; 2016 Jun; 195(6):1911-9. PubMed ID: 26802582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
    Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
    Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine metabolic signature of pancreatic ductal adenocarcinoma by (1)h nuclear magnetic resonance: identification, mapping, and evolution.
    Napoli C; Sperandio N; Lawlor RT; Scarpa A; Molinari H; Assfalg M
    J Proteome Res; 2012 Feb; 11(2):1274-83. PubMed ID: 22066465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiome-metabolomic analysis of the impact of Zizyphus jujuba cv. Muzao polysaccharides consumption on colorectal cancer mice fecal microbiota and metabolites.
    Ji X; Hou C; Zhang X; Han L; Yin S; Peng Q; Wang M
    Int J Biol Macromol; 2019 Jun; 131():1067-1076. PubMed ID: 30926487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolomics in pancreatic cancer biomarkers research.
    Tumas J; Kvederaviciute K; Petrulionis M; Kurlinkus B; Rimkus A; Sakalauskaite G; Cicenas J; Sileikis A
    Med Oncol; 2016 Dec; 33(12):133. PubMed ID: 27807722
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.